Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PERKINELMER, INC.

(PKI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
182.86(c) 183.38(c) 186.84(c) 185.87(c) 187.56(c) Last
755 759 424 639 1 119 387 770 463 1 465 356 Volume
-2.24% +0.28% +1.89% -0.52% +0.91% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 4 605 M - -
Net income 2021 902 M - -
Net Debt 2021 2 239 M - -
P/E ratio 2021 23,4x
Yield 2021 0,15%
Sales 2022 3 858 M - -
Net income 2022 529 M - -
Net Debt 2022 726 M - -
P/E ratio 2022 39,8x
Yield 2022 0,15%
Capitalization 21 028 M 21 028 M -
EV / Sales 2021 5,05x
EV / Sales 2022 5,64x
Nbr of Employees 14 000
Free-Float 99,7%
More Financials
Company
PerkinElmer Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Its Discovery & Analytical Solutions segment serves the life sciences and applied markets. Through the Diagnostics Segment, it offers instruments, reagents, assay platforms, and software to hospitals,... 
More about the company
Ratings of PerkinElmer, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about PERKINELMER, INC.
09/17PERKINELMER : Completes $5.25 Billion Acquisition of BioLegend
MT
09/17PERKINELMER : Completes Acquisition of Antibody and Reagent Leader BioLegend
BU
09/17PerkinElmer, Inc. completed the acquisition of BioLegend, Inc.
CI
09/10PERKINELMER INC : Entry into a Material Definitive Agreement, Other Events (form..
AQ
09/09PERKINELMER : Prices Offering of $2.30 Billion Senior Notes
MT
09/08PERKINELMER : Prices Offering of Senior Notes
BU
09/08PerkinElmer, Inc. Prices Offering of Senior Notes
CI
09/08PERKINELMER : Introduces IndiScope™ Solution to Help Dairy Collection Poin..
PU
09/07BICO : Names First Chief People Officer
MT
08/25PERKINELMER INC : Entry into a Material Definitive Agreement, Termination of a M..
AQ
08/25Perkinelmer, Inc. Enters into an Unsecured Revolving Credit Facility with Per..
CI
08/24PERKINELMER : to Present at 2021 Baird Global Healthcare Conference
BU
08/19PerkinElmer Expands Automated Mycotoxin Detection Kits Portfolio to Include A..
CI
08/12PERKINELMER INC : Entry into a Material Definitive Agreement, Creation of a Dire..
AQ
08/12PerkinElmer, Inc. Enters into an Unsecured Delayed Draw Term Loan Credit Faci..
CI
More news
News in other languages on PERKINELMER, INC.
09/17PerkinElmer achève l'acquisition de BioLegend pour 5,25 milliards de dollars.
09/09PerkinElmer propose des obligations de premier rang d'une valeur de 2,30 mill..
06/16WALL STREET STOCK EXCHANGE : Cómo podrían afectar los datos de ayer a la polític..
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -4-
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -2-
More news
Analyst Recommendations on PERKINELMER, INC.
More recommendations
Stock Trading Strategies
PERKINELMER, INC. - 05/17
Technically solid
BUY
More Stock Trading Analysis
Chart PERKINELMER, INC.
Duration : Period :
PerkinElmer, Inc. Technical Analysis Chart | PKI | US7140461093 | MarketScreener
Technical analysis trends PERKINELMER, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 187,56 $
Average target price 176,42 $
Spread / Average Target -5,94%
EPS Revisions
Managers and Directors
Prahlad Ramadhar Singh President, CEO, COO & Director
James M. Mock Chief Financial Officer & Senior Vice President
Alexis Platon Michas Non-Executive Chairman
Joel S. Goldberg Secretary, SVP-Administration & General Counsel
Peter Barrett Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PERKINELMER, INC.29.53%21 028
THERMO FISHER SCIENTIFIC20.32%234 792
DANAHER CORPORATION45.85%231 682
INTUITIVE SURGICAL, INC.26.79%123 426
SIEMENS HEALTHINEERS AG39.64%77 234
EDWARDS LIFESCIENCES CORPORATION32.29%74 438